Previous studies have identified that APOE4 carriers classified to be cognitively normal exhibit GMV changes in regions essential for cognitive function, such as in the hippocampus and insula, suggesting that these structural alterations may precede the development of cognitive impairment [22,24,25]. Here, APOE is linked to Cognitive impairment.